Inventor · disambiguated record
Howard Dittrich
Also filed as: DITTRICH HOWARD · DITTRICH HOWARD C
2 granted patents·21 pending applications·184 citations·filing 1996–2024
62Inventor score
Top patents by PatentIndex Score
23 records- 0189US5776063AAnalysis of ultrasound images in the presence of contrast agentMOLECULAR BIOSYSTEMS INC·Filed 1996·Granted Jul 7, 1998·184 cites·66 claims
- 0262US2024216344A1Thiazolidinedione analogs for the treatment of nafld and metabolic diseasesCIRIUS THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 0356US2023013627A1Thiazolidinedione analogs for the treatment of nafld and metabolic diseasesCIRIUS THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 0452US2016303113A1Methods of self-administration of vanoxerine for terminating acute episodes of cardiac arrhythmia in mammalsLAGUNA PHARMACEUTICALS INC·Filed 2014·Application pending·0 cites
- 0551US2016038482A1Vanoxerine for self-administration for terminating acute episodes of cardiac arrhythmia in mammalsCHANRX CORP·Filed 2014·Application pending·0 cites
- 0650US2009197900A1Methods of treating heart failure and renal dysfunction in individuals with an adenosine a1 receptor antagonistDITTRICH HOWARD·Filed 2008·Application pending·0 cites
- 0749US2009253665A1Method of treatment of disease using an adenosine a1 receptor antagonist and an aldosterone inhibitorOTSUKI LAUREN·Filed 2009·Application pending·0 cites
- 0849US2009118334A1Method of treatment of cardiac and/or renal failure using a calcium channel blocker and an angiotensin converting enzyme inhibitor or an angiotensin ii receptor blockerDIAKRON PHARMACEUTICALS INC·Filed 2009·Application pending·0 cites
- 0947US2016051541A1Pharmaceutical compositions comprising vanoxerine and antianginal compounds, and methods of administration of the same for treating episodes of cardiac arrhythmia, maintaining normal sinus rhythm, preventing recurrence of cardiac arrhythmia, and treatment of chronic cardiac arrhythmia in mammalsCHANRX CORP·Filed 2014·Application pending·0 cites
- 1046US2022031667A1Thiazolidinedione analogs for the treatment of nafld and metabolic diseasesCIRIUS THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 1144US2008070934A1Kw-3902 conjugates that do not cross the blood-brain barrierMUGERDITICHIAN MARK·Filed 2007·Application pending·0 cites
- 1243US2006030572A1Method of improved diuresis in individuals with impaired renal functionWIDDER KENNETH J·Filed 2005·Application pending·0 cites
- 1343US2006035911A1Method of improved diuresis in individuals with impaired renal functionWIDDER KENNETH J·Filed 2005·Application pending·0 cites
- 1442US7579331B2Method of improved diuresis in individuals with impaired renal functionNOVACARDIA INC·Filed 2004·Granted Aug 25, 2009·0 cites·51 claims
- 1542US2007238672A1Co-administration of adenosine a1 receptor antagonists and anticonvulsantsDITTRICH HOWARD·Filed 2007·Application pending·0 cites
- 1641US2007293463A1Method for shortening hospital stay in patients with congestive heart failure and acute fluid overloadDITTRICH HOWARD·Filed 2007·Application pending·0 cites
- 1741US2007293518A1Prolonged improvement of renal function comprising infrequent administration of an aa1raDITTRICH HOWARD·Filed 2007·Application pending·0 cites
- 1839US2006058355A1Method of treatment of cardiac and/or renal failure using a calcium channel blocker and an angiotensin converting enzyme inhibitor or an angiotensin II receptor blockerDITTRICH HOWARD C·Filed 2005·Application pending·0 cites
- 1939US2008242684A1Methods of administration of adenosine a1 receptor antagonistsDITTRICH HOWARD·Filed 2008·Application pending·0 cites
- 2038US2006293312A1Method of improved diuresis in individuals with impaired renal functionDITTRICH HOWARD·Filed 2006·Application pending·0 cites
- 2138US2005239759A1Method of treatment of disease using an adenosine A1 receptor antagonist and an aldosterone inhibitorOTSUKI LAUREN·Filed 2005·Application pending·0 cites
- 2237US2016244453A1Treatment of viral and infectious diseases using an inhibitor of cbp/cateninPRISM PHARMA CO LTD·Filed 2013·Application pending·0 cites
- 2333US2004229901A1Method of treatment of disease using an adenosine A1 receptor antagonistFiled 2004·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →